Furthermore, experimental modulation of hnRNPL expression regulated the expression of the two CASP9 variants in NSCLC cells, with knockdown abrogating clonogenic growth and xenograft tumor formation [243]. The gene discussed is HNRNPL; the disease is non-small cell lung carcinoma.